Patent Armory v. Inovalon Holdings: Five Routing Patents Dismissed With Prejudice in 47 Days
Patent Armory, Inc. asserted five U.S. patents covering intelligent call routing, telephony control, and auction-based entity matching against Inovalon Holdings, Inc. in the Delaware District Court. The parties reached a stipulated dismissal with prejudice of all claims in just 47 days — an unusually swift resolution that suggests a rapid settlement or licensing agreement was reached.
Five-Patent Routing Dispute Resolved in Under Two Months
On April 17, 2025, Patent Armory, Inc. filed an infringement action against Inovalon Holdings, Inc. in the U.S. District Court for the District of Delaware (Case No. 1:25-cv-00472), before Judge Maryellen Noreika. The complaint asserted five U.S. patents — US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1 — covering intelligent communication routing, telephony control systems, and auction-based entity-matching methods. Inovalon is a data-driven healthcare technology company, making the routing and entity-matching patents particularly relevant to its platform infrastructure.
The case closed on June 3, 2025, just 47 days after filing, via a stipulated dismissal filed pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(ii). All claims against Inovalon were dismissed with prejudice, meaning Patent Armory is permanently barred from re-asserting these patents against Inovalon in future litigation. Inovalon’s counterclaims were dismissed without prejudice, preserving its ability to refile those claims if needed. Each party agreed to bear its own costs, attorneys’ fees, and expenses.
A 47-day lifecycle — from filing to dismissal — is consistent with a pre-discovery settlement or licensing agreement reached shortly after the complaint was filed. The with-prejudice dismissal of plaintiff’s claims strongly suggests the dispute was commercially resolved rather than abandoned. The public record does not disclose any financial terms. It remains unknown whether a license was granted, a lump-sum payment made, or whether Inovalon disputed infringement and Patent Armory concluded the case lacked sufficient merit to pursue.
Filing to Dismissed with Prejudice in 47 days
47 days — well below the median district court patent case duration of 2–3 years
Stipulated dismissal with prejudice: what the terms mean for both parties
Rule 41(a)(1)(A)(ii) stipulated dismissal explained
A dismissal under Fed. R. Civ. P. 41(a)(1)(A)(ii) requires agreement from all parties who have appeared. It carries no court merits ruling — no finding of infringement or invalidity. Dismissal with prejudice of plaintiff’s claims operates as a final adjudication on the merits, permanently extinguishing Patent Armory’s right to sue Inovalon on these five patents again. The without-prejudice dismissal of counterclaims leaves those claims legally alive for Inovalon if circumstances change.
Stipulated — no merits rulingPatent Armory permanently barred from re-suing Inovalon
The with-prejudice dismissal of all of Patent Armory’s claims is the most consequential term for the plaintiff. It forecloses any future infringement action against Inovalon under these five patents — regardless of any new products or continued alleged infringement. This is a significant concession that typically accompanies a commercial resolution. Patent Armory retains the ability to assert these patents against other defendants not party to this stipulation.
Claims extinguished vs. InovalonInovalon’s counterclaims survive — dismissed without prejudice
Inovalon secured dismissal of Patent Armory’s claims with prejudice while preserving its own counterclaims by having them dismissed without prejudice. This asymmetric structure is strategically significant: Inovalon retains the option to refile counterclaims — potentially including invalidity or unenforceability challenges — if Patent Armory pursues similar assertions against third parties or takes positions inconsistent with any undisclosed settlement terms. Each party bearing its own fees suggests neither party was found to have litigated in bad faith.
Counterclaims preservedSwift resolution signals rapid licensing or commercial settlement
A 47-day case lifecycle — shorter than many pre-answer periods in complex patent cases — strongly suggests a commercial resolution was reached before meaningful discovery. For the healthcare technology sector, this pattern is consistent with patent assertion entities securing rapid licensing fees rather than pursuing full merits litigation. Companies operating routing, entity-matching, or healthcare communication platforms should assess whether Patent Armory is asserting these same patents across the industry.
Likely rapid licensing resolutionFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Patent Armory, Inc. | Company | Patent assertion entity — holder of US9456086B1, US10491748B1, US7269253B1, US7023979B1, US10237420B1Search in Eureka ↗ |
| Defendant | Inovalon Holdings, Inc. | Company | Inovalon Holdings, Inc. — data-driven healthcare technology and cloud analytics platform providerSearch in Eureka ↗ |
| Plaintiff counsel | Antranig N. Garibian | Attorney | Counsel for Patent Armory, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Garibian Law Offices, PC | Law Firm | Representing Patent Armory, Inc.Search in Eureka ↗ |
| Defendant counsel | Grayson P. Sundermeir | Attorney | Counsel for Inovalon Holdings, Inc.Search in Eureka ↗ |
| Defendant law firm | Fish & Richardson PC | Law Firm | Representing Inovalon Holdings, Inc.Search in Eureka ↗ |
| Presiding judge | Judge Maryellen Noreika | Judge | Delaware District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulation’s asymmetric structure — with-prejudice dismissal of plaintiff’s claims alongside without-prejudice dismissal of defendant’s counterclaims — is a deliberate and significant drafting choice. It reflects a negotiated outcome where Inovalon secured permanent protection from re-litigation while retaining the optionality of its own counterclaims. No court finding was made on infringement, validity, or claim scope. The fee-neutrality clause, each party bearing its own costs, is consistent with a confidential commercial resolution rather than a concession of weakness by either side.
US9456086B1 and four further patents — intelligent call routing and entity-matching systems
The five asserted patents cover a cluster of related technologies: intelligent routing of communications (US9456086B1, US10491748B1, US10237420B1), telephony control systems with call-routing logic (US7269253B1), and auction-based entity-matching methods (US7023979B1). Application dates range from the early 2000s (US10/385389, US11/387305) through 2017 (US15/856729), suggesting a deliberate portfolio-building strategy that layered newer continuation-style claims onto foundational earlier inventions. All five issued as B1 grants, indicating no published pre-grant history.
For healthcare technology companies, these patents are strategically significant because intelligent routing and entity-matching are core infrastructure functions in claims processing, patient communication platforms, provider-payer matching, and care coordination systems. Inovalon’s data platform sits squarely in this intersection. Any company operating automated routing of healthcare communications or deploying auction-style matching for provider or payer entities should assess claim scope across these five patents. The portfolio’s age and breadth suggest it was assembled for assertion rather than practising product development.
Should you run an FTO against US9456086B1 and the Patent Armory routing portfolio?
If your product involves intelligent routing of communications, telephony control logic, or auction-based matching of entities — particularly in healthcare, insurance, or data platform contexts — these five patents warrant a freedom-to-operate review. Patent Armory’s willingness to file in Delaware and secure a rapid with-prejudice settlement signals active enforcement. The portfolio spans over 15 years of application filings, which typically means claim language has been tailored across multiple generations to capture evolving product implementations.
PatSnap Eureka’s FTO Search Agent can map independent claim elements from all five asserted patents against your product architecture, flag prior art that may support invalidity arguments, and identify continuation applications that may generate future claim risk. Given the PAE enforcement pattern visible in this case, a proactive FTO review — rather than a reactive litigation response — is the lower-cost path for healthcare technology and communications platform operators.
Run a freedom-to-operate analysis on US9456086B1 to assess your product’s exposure
Run FTO in Eureka →Similar call routing and PAE patent cases in Delaware District Court
Explore patent assertion entity cases involving intelligent call routing, telephony control, and entity-matching patents litigated in the Delaware District Court.
What this case signals for the healthcare technology IP landscape
A 47-day lifecycle and with-prejudice dismissal in a five-patent case carries tactical lessons for both PAE targets and routing-technology operators.
Early engagement can compress litigation timelines dramatically
Patent Armory’s case closed in 47 days — suggesting Inovalon’s counsel at Fish & Richardson moved quickly to assess exposure and negotiate terms before discovery began. For defendants facing multi-patent assertion entity claims, early landscape analysis of the asserted patents’ validity and claim scope can accelerate resolution and reduce litigation spend significantly.
With-prejudice dismissal protects Inovalon but leaves third parties exposed
The dismissal with prejudice binds only the named parties. Patent Armory retains full enforcement rights against any other company operating intelligent call routing, telephony control, or auction-based entity-matching systems. Companies in adjacent healthcare technology, communications routing, or insurance platform sectors should treat this case as an active enforcement signal and monitor Patent Armory’s filing activity.
Patent v Inovalon — key questions answered
Patent Armory, Inc. filed a five-patent infringement action against Inovalon Holdings, Inc. in the Delaware District Court on April 17, 2025. The case was dismissed 47 days later, on June 3, 2025, via a stipulated dismissal. All claims against Inovalon were dismissed with prejudice; Inovalon’s counterclaims were dismissed without prejudice. Each party bore its own costs and fees.
Dismissal with prejudice operates as a final adjudication on the merits under U.S. federal procedure. Patent Armory is permanently barred from bringing any of these five patent claims against Inovalon in future litigation. However, the dismissal applies only to Inovalon — Patent Armory retains the right to assert the same patents against other defendants.
Patent Armory asserted five U.S. patents: US9456086B1, US10491748B1, US7269253B1, US7023979B1, and US10237420B1. These cover intelligent communication routing systems, telephony control systems with intelligent call routing, and methods for matching entities in an auction. Application dates range from the early 2000s to 2017.
The 47-day duration — from filing to stipulated dismissal — is consistent with a rapid commercial settlement or licensing agreement reached before discovery commenced. The with-prejudice dismissal of Patent Armory’s claims, combined with each party bearing its own costs, suggests a negotiated resolution rather than a unilateral abandonment. The specific financial terms are not disclosed in the public record.
This asymmetric structure reflects a deliberate negotiated outcome. Inovalon secured permanent protection from re-litigation by Patent Armory on these patents (with-prejudice dismissal of claims), while preserving optionality on its own counterclaims (without-prejudice dismissal). This allows Inovalon to refile counterclaims — potentially including invalidity challenges — if future circumstances warrant, without those claims being treated as waived.
PatSnap Eureka searches patents and litigation data to answer instantly.